comparemela.com

Latest Breaking News On - Gables capital management - Page 1 : comparemela.com

Vinva Investment Management Ltd Grows Stake in Trane Technologies plc (NYSE:TT)

Vinva Investment Management Ltd boosted its position in shares of Trane Technologies plc (NYSE:TT – Free Report) by 5.5% in the fourth quarter, Holdings Channel reports. The fund owned 6,971 shares of the company’s stock after purchasing an additional 365 shares during the quarter. Vinva Investment Management Ltd’s holdings in Trane Technologies were worth $1,700,000 […]

930 Shares in Trane Technologies plc (NYSE:TT) Bought by Allstate Corp

930 Shares in Trane Technologies plc (NYSE:TT) Bought by Allstate Corp
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

CreativeOne Wealth LLC Lowers Position in Vanguard Financials ETF (NYSEARCA:VFH)

CreativeOne Wealth LLC reduced its position in Vanguard Financials ETF (NYSEARCA:VFH – Free Report) by 5.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,185 shares of the company’s stock after selling 575 shares during the period. CreativeOne Wealth […]

FineMark National Bank & Trust Has $13 30 Million Stake in Trane Technologies plc (NYSE:TT)

FineMark National Bank & Trust raised its position in Trane Technologies plc (NYSE:TT – Free Report) by 0.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 54,528 shares of the company’s stock after purchasing an additional 399 shares during the quarter. FineMark National […]

HC Wainwright Reaffirms Buy Rating for Outlook Therapeutics (NASDAQ:OTLK)

HC Wainwright reissued their buy rating on shares of Outlook Therapeutics (NASDAQ:OTLK – Free Report) in a report published on Friday, Benzinga reports. HC Wainwright currently has a $30.00 price target on the stock. HC Wainwright also issued estimates for Outlook Therapeutics’ Q1 2025 earnings at ($1.00) EPS, Q2 2025 earnings at ($0.50) EPS, Q3 […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.